Your browser doesn't support javascript.
loading
Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy.
Wakiyama, Hiroaki; Kato, Takuya; Furusawa, Aki; Okada, Ryuhei; Inagaki, Fuyuki; Furumoto, Hideyuki; Fukushima, Hiroshi; Okuyama, Shuhei; Choyke, Peter L; Kobayashi, Hisataka.
Affiliation
  • Wakiyama H; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Kato T; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Furusawa A; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Okada R; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Inagaki F; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Furumoto H; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Fukushima H; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Okuyama S; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Choyke PL; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Kobayashi H; Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Cancer Immunol Res ; 10(11): 1386-1397, 2022 11 02.
Article de En | MEDLINE | ID: mdl-36169564

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T régulateurs / Tumeurs Limites: Animals Langue: En Journal: Cancer Immunol Res Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T régulateurs / Tumeurs Limites: Animals Langue: En Journal: Cancer Immunol Res Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique